HOUSE DOCKET, NO. 1270 FILED ON: 1/18/2023
HOUSE . . . . . . . . . . . . . . . No. 976
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Rob Consalvo and John J. Lawn, Jr.
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act requiring full health insurance coverage for individuals with vitiligo.
_______________
PETITION OF:
Name: | District/Address: | Date Added: |
Rob Consalvo | 14th Suffolk | 1/17/2023 |
John J. Lawn, Jr. | 10th Middlesex | 1/18/2023 |
Brian M. Ashe | 2nd Hampden | 6/21/2023 |
Sean Garballey | 23rd Middlesex | 6/29/2023 |
Bud L. Williams | 11th Hampden | 6/29/2023 |
Dawne Shand | 1st Essex | 6/30/2023 |
Brandy Fluker Oakley | 12th Suffolk | 7/12/2023 |
HOUSE DOCKET, NO. 1270 FILED ON: 1/18/2023
HOUSE . . . . . . . . . . . . . . . No. 976
By Representatives Consalvo of Boston and Lawn of Watertown, a petition (accompanied by bill, House, No. 976) of Rob Consalvo and John J. Lawn, Jr. for legislation to provide health insurance coverage for individuals with vitiligo. Financial Services. |
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Third General Court
(2023-2024)
_______________
An Act requiring full health insurance coverage for individuals with vitiligo.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. Chapter 32A of the General Laws is hereby amended by inserting after section 17S the following section:-
Section 17T. The commission shall provide, to an active or retired employee of the commonwealth who is insured under the group insurance commission, coverage for treatment of vitiligo as a chronic autoimmune disease including, but not limited to, mental health treatment in connection with vitiligo.
SECTION 2. Chapter 118E of the General laws is hereby amended by inserting after section 10Q the following section:-
Section 10R. The division and its contracted health insurers, health plans, health maintenance organizations, behavioral health management firms and third-party administrators under contract to a Medicaid managed care organization or primary care clinician plan shall provide coverage for treatment of vitiligo as a chronic autoimmune disease including, but not limited to, mental health treatment in connection with vitiligo.
SECTION 3. Chapter 175 of the General Laws is hereby amended by inserting after section 47TT the following section:-
Section 47UU. Any policy, contract, agreement, plan or certificate of insurance issued, delivered or renewed within or without the commonwealth shall provide coverage for treatment of vitiligo as a chronic autoimmune disease including, but not limited to, mental health treatment in connection with vitiligo.
SECTION 4. Chapter 176A of the General Laws is hereby amended by inserting after section 8UU the following section:-
Section 8VV. A contract between a subscriber and the corporation under an individual or group hospital service plan that is delivered, issued or renewed within the commonwealth shall provide coverage for treatment of vitiligo as a chronic autoimmune disease including, but not limited to, mental health treatment in connection with vitiligo.
SECTION 5. Chapter 176B of the General Laws is hereby amended by inserting after section 4UU the following section:-
Section 4VV. Any subscription certificate under an individual or group medical service agreement delivered, issued or renewed within the commonwealth shall provide coverage for treatment of vitiligo as a chronic autoimmune disease including, but not limited to, mental health treatment in connection with vitiligo.
SECTION 6. Chapter 176G of the General Laws is hereby amended by inserting after section 4MM the following section:-
Section 4NN. Any individual or group health maintenance contract that is issued or renewed within or without the commonwealth shall provide coverage for treatment of vitiligo as a chronic autoimmune disease including, but not limited to, mental health treatment in connection with vitiligo.